211 related articles for article (PubMed ID: 17700258)
1. Adherence to hepatitis C treatment in recovering heroin users maintained on methadone.
Sylvestre DL; Clements BJ
Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):741-7. PubMed ID: 17700258
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules?
Schaefer M; Heinz A; Backmund M
Addiction; 2004 Sep; 99(9):1167-75. PubMed ID: 15317637
[TBL] [Abstract][Full Text] [Related]
3. The impact of barriers to hepatitis C virus treatment in recovering heroin users maintained on methadone.
Sylvestre DL; Litwin AH; Clements BJ; Gourevitch MN
J Subst Abuse Treat; 2005 Oct; 29(3):159-65. PubMed ID: 16183464
[TBL] [Abstract][Full Text] [Related]
4. Cannabis use improves retention and virological outcomes in patients treated for hepatitis C.
Sylvestre DL; Clements BJ; Malibu Y
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1057-63. PubMed ID: 16957511
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects.
Schaefer M; Hinzpeter A; Mohmand A; Janssen G; Pich M; Schwaiger M; Sarkar R; Friebe A; Heinz A; Kluschke M; Ziemer M; Gutsche J; Weich V; Halangk J; Berg T
Hepatology; 2007 Oct; 46(4):991-8. PubMed ID: 17668880
[TBL] [Abstract][Full Text] [Related]
6. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.
Schaefer M; Schmidt F; Folwaczny C; Lorenz R; Martin G; Schindlbeck N; Heldwein W; Soyka M; Grunze H; Koenig A; Loeschke K
Hepatology; 2003 Feb; 37(2):443-51. PubMed ID: 12540795
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program.
Litwin AH; Harris KA; Nahvi S; Zamor PJ; Soloway IJ; Tenore PL; Kaswan D; Gourevitch MN; Arnsten JH
J Subst Abuse Treat; 2009 Jul; 37(1):32-40. PubMed ID: 19038524
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of chronic hepatitis C treatment in drug users in routine clinical practice: results of a prospective cohort study.
Melin P; Chousterman M; Fontanges T; Ouzan D; Rotily M; Lang JP; Marcellin P; Cacoub P;
Eur J Gastroenterol Hepatol; 2010 Sep; 22(9):1050-7. PubMed ID: 20351554
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C testing and treatment among active drug users in Amsterdam: results from the DUTCH-C project.
Lindenburg CE; Lambers FA; Urbanus AT; Schinkel J; Jansen PL; Krol A; Casteelen G; van Santen G; van den Berg CH; Coutinho RA; Prins M; Weegink CJ
Eur J Gastroenterol Hepatol; 2011 Jan; 23(1):23-31. PubMed ID: 21042221
[TBL] [Abstract][Full Text] [Related]
10. A prospective controlled study of interferon-based therapy of chronic hepatitis C in patients on methadone maintenance.
Mauss S; Berger F; Goelz J; Jacob B; Schmutz G
Hepatology; 2004 Jul; 40(1):120-4. PubMed ID: 15239094
[TBL] [Abstract][Full Text] [Related]
11. Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C.
Fabris P; Brown D; Tositti G; Bozzola L; Giordani MT; Bevilacqua P; de Lalla F; Webster GJ; Dusheiko G
J Clin Virol; 2004 Mar; 29(3):160-6. PubMed ID: 14962784
[TBL] [Abstract][Full Text] [Related]
12. Approaching treatment for hepatitis C virus infection in substance users.
Sylvestre DL
Clin Infect Dis; 2005 Jul; 41 Suppl 1():S79-82. PubMed ID: 16265620
[TBL] [Abstract][Full Text] [Related]
13. Treating hepatitis C virus infection in active substance users.
Sylvestre DL
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S321-4. PubMed ID: 15768341
[TBL] [Abstract][Full Text] [Related]
14. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP;
Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C treatment of opioid dependants receiving maintenance treatment: results of a Norwegian pilot study.
Krook AL; Stokka D; Heger B; Nygaard E
Eur Addict Res; 2007; 13(4):216-21. PubMed ID: 17851243
[TBL] [Abstract][Full Text] [Related]
16. Rationale and design of a randomized controlled trial of directly observed hepatitis C treatment delivered in methadone clinics.
Litwin AH; Berg KM; Li X; Hidalgo J; Arnsten JH
BMC Infect Dis; 2011 Nov; 11():315. PubMed ID: 22078241
[TBL] [Abstract][Full Text] [Related]
17. Treating chronic hepatitis C in recovering opiate addicts: yes, we can.
Kreek MJ; Talal AH; Piccolo P
Dig Liver Dis; 2009 Apr; 41(4):308-10. PubMed ID: 19233749
[No Abstract] [Full Text] [Related]
18. Interferon alpha-2a plus ribavirin 1,000/1,200 mg versus interferon alpha-2a plus ribavirin 600 mg for chronic hepatitis C infection in patients on opiate maintenance treatment: an open-label randomized multicenter trial.
Huber M; Weber R; Oppliger R; Vernazza P; Schmid P; Schönbucher P; Bertisch B; Meili D; Renner EL
Infection; 2005 Feb; 33(1):25-9. PubMed ID: 15750756
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C treatment in an HIV-HCV-coinfected patient with drug addiction and psychiatric illness: a case report.
Taylor LE; Gholam PM; Schwartzapfel B; Rich JD
AIDS Read; 2005 Nov; 15(11):629-31, 634-6, 638. PubMed ID: 16323305
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus eradication in intravenous drug users maintained with subcutaneous naltrexone implants.
Jeffrey GP; MacQuillan G; Chua F; Galhenage S; Bull J; Young E; Hulse G; O'Neil G
Hepatology; 2007 Jan; 45(1):111-7. PubMed ID: 17187435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
